Diamanti-Kandarakis E - Search Results

1

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.

Androulakis II, Kandaraki E, Christakou C, Karachalios A, Marinakis E, Paterakis T, Diamanti-Kandarakis E. Androulakis II, et al. Clin Endocrinol (Oxf). 2014 Sep;81(3):426-31. doi: 10.1111/cen.12447. Epub 2014 Apr 15. Clin Endocrinol (Oxf). 2014. PMID: 24601936

2

Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.

Diamanti-Kandarakis E, Alexandraki K, Piperi C, Aessopos A, Paterakis T, Katsikis I, Panidis D. Diamanti-Kandarakis E, et al. Metabolism. 2007 Jan;56(1):129-34. doi: 10.1016/j.metabol.2006.09.006. Metabolism. 2007. PMID: 17161235

3

Indices of low-grade inflammation in polycystic ovary syndrome.

Diamanti-Kandarakis E, Paterakis T, Kandarakis HA. Diamanti-Kandarakis E, et al. Ann N Y Acad Sci. 2006 Dec;1092:175-86. doi: 10.1196/annals.1365.015. Ann N Y Acad Sci. 2006. PMID: 17308143 Review.

4

Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?

Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Alexandraki KI. Diamanti-Kandarakis E, et al. Hormones (Athens). 2007 Jul-Sep;6(3):210-7. Hormones (Athens). 2007. PMID: 17724005 Free article. Review.

5

Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).

Diamanti-Kandarakis E, Katsikis I, Piperi C, Kandaraki E, Piouka A, Papavassiliou AG, Panidis D. Diamanti-Kandarakis E, et al. Clin Endocrinol (Oxf). 2008 Oct;69(4):634-41. doi: 10.1111/j.1365-2265.2008.03247.x. Epub 2008 Mar 19. Clin Endocrinol (Oxf). 2008. PMID: 18363886

6

Does polycystic ovary syndrome start in childhood?

Diamanti-Kandarakis E, Christakou C, Palioura E, Kandaraki E, Livadas S. Diamanti-Kandarakis E, et al. Pediatr Endocrinol Rev. 2008 Jun;5(4):904-11. Pediatr Endocrinol Rev. 2008. PMID: 18552753 Review.

7

Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome.

Christakou CD, Diamanti-Kandarakis E. Christakou CD, et al. Womens Health (Lond). 2008 Nov;4(6):583-94. doi: 10.2217/17455057.4.6.583. Womens Health (Lond). 2008. PMID: 19072461 Free article. Review.

8

In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls.

Economou F, Xyrafis X, Livadas S, Androulakis II, Argyrakopoulou G, Christakou CD, Kandaraki E, Palioura E, Diamanti-Kandarakis E. Economou F, et al. Hormones (Athens). 2009 Jul-Sep;8(3):199-206. doi: 10.14310/horm.2002.1236. Hormones (Athens). 2009. PMID: 19671519 Free article.

9

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.

Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN. Diamanti-Kandarakis E, et al. Eur J Endocrinol. 2010 Feb;162(2):193-212. doi: 10.1530/EJE-09-0733. Epub 2009 Oct 19. Eur J Endocrinol. 2010. PMID: 19841045 Review.

10

Metformin in polycystic ovary syndrome.

Diamanti-Kandarakis E, Economou F, Palimeri S, Christakou C. Diamanti-Kandarakis E, et al. Ann N Y Acad Sci. 2010 Sep;1205:192-8. doi: 10.1111/j.1749-6632.2010.05679.x. Ann N Y Acad Sci. 2010. PMID: 20840272 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters